Profiel
Paul J.
Carter worked as a Founding Director at Immunex Corp.
from 2000 to 2002.
He then worked as a Research Director at Amgen, Inc. in 2003.
From 2003 to 2008, he worked as a Vice President at Seagen Inc. He also served as the Chief Scientific Officer at Viral Logic Systems Technology Corp.
Dr. Carter received his undergraduate degree in 1982 and his doctorate in 1986 from the University of Cambridge.
Eerdere bekende functies van Paul J. Carter
| Bedrijven | Functie | Einde |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 01-01-2008 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01-01-2003 |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Corporate Officer/Principal | 01-01-2002 |
Viral Logic Systems Technology Corp.
 Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Viral Logic Systems Technology Corp. provides pharmaceutical products and services. It develops treatments for autoimmune, inflammatory diseases and disorders. The company was founded by Steven R. Wiley and Craig A. Smith in 2004 and headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Paul J. Carter
| University of Cambridge | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Viral Logic Systems Technology Corp.
Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Viral Logic Systems Technology Corp. provides pharmaceutical products and services. It develops treatments for autoimmune, inflammatory diseases and disorders. The company was founded by Steven R. Wiley and Craig A. Smith in 2004 and headquartered in Seattle, WA. | Health Technology |
